Artigos completos publicados em periódicos
BEZERRA, PATRICIA C.F.M., LEÃO, MARCOS D., QUEIROZ, JOSÉ W., MELO, EDAILNA M.D., PEREIRA, FLÁVIO V.M., NÓBREGA, MARIA HEBE, JERONIMO, ANA K., FERREIRA, LEONARDO C., JERÔNIMO, SELMA M.B., DE ARAÚJO, ANA CRISTINA P.F. Family history of hypertension as an important risk factor for the
development of severe preeclampsia. Acta Obstetricia et Gynecologica Scandinavica. , v.89, p.612 - 617, 2010.
BEZERRA, P. F. C. F, ARAÚJO, A. C. P. F., JERONIMO, Selma Maria Bezerra, LEAO, Marcos Dias, MARANHAO, T. M. O, PEREIRA, Flavio Venicio M, ; DANTAS, Edailna Maria Melo, DANTAS, E. M. M. Síndrome HELLP: considerações acerca do diagnóstico e conduta. Femina (Rio de Janeiro). , v.35, p.585 - 590, 2007.
ARAÚJO, A. C. P. F, ; DANTAS, Edailna Maria Melo, JERONIMO, Selma Maria Bezerra, ; OLIVEIRA, M. H. N., AZEVEDO, George Dantas de, Patrícia Costa F M, LEAO, Marcos Dias, M, F. V.Flavio Venicio M, DANTAS, E. M. M. Characteristics and treatment of hepatic rupture caused by HELLP syndrome. American Journal of Obstetrics and Gynecology (Online). , v.195, p.129 - 133, 2006.
Trabalhos publicados em anais de eventos (completo)
ARAÚJO, A. C. P. F, MACEDO, ALB, DANTAS, E. M. M., JERONIMO, Selma Maria Bezerra, ; FERREIRA, L. C, moreira, YCB VALIDAÇÃO DE AGREGAÇÃO FAMILIAR EM HIPERTENSÃO ARTERIAL NA GRAVIDEZ In: 53 CONGRESSO DE GINECOLOGIA OBSTETRICIA, 2009, Belo Horizonte.
Trabalhos publicados em anais de eventos (resumo)
MELO, EDAILNA M.D., BEZERRA, P. F. C. F, ARAÚJO, A. C. P. F., PEREIRA, Flavio Venicio M, ; Queiroz, JWFamily history of hypertension is a risk factor for development of eclampsia and HELLP syndrome in a Brazilian Population In: XIX FIGO WORLD CONGRESS OF GYNECOLOGY AND OBSTETRICS, 2009, CAPE TOWN. Abstracts XIX FIGO World Congress of Gynecology and Obstetrics. , 2009. v.107-S2. p.S457 - S457
MELO, EDAILNA M.D., ARAÚJO, A. C. P. F, BEZERRA, P. F. C. F, LEAO, Marcos Dias, PEREIRA, Flavio Venicio M, ARAÚJO, A. C. P. F. ECLÂMPSIA E SÍNDROME HELLP - Agregação Familiar no Rio Grande do Norte In: 51º Congresso Brasileiro de Ginecologia e Obstetrícia, 2005, Rio de Janeiro. Anais do 51º Congresso Brasileiro de Ginecologia e Obstetrícia. , 2005. p.770 - 770
DANTAS, E. M. M., ARAÚJO, A. C. P. F, LEAO, Marcos Dias, PEREIRA, Flavio Venicio M, ARAÚJO, A. C. P. F. IMPACTO DA CORTICOTERAPIA NA SÍNDROME HELLP In: 51º CONGRESSO BRASILEIRO DE GINECOLOGIA E OBSTETRÍCIA, 2005, RIO DE JANEIRO. Anais do 51º Congresso Brasileiro de Ginecologia e Obstetrícia. , 2005. v.01. p.766 - 766
DANTAS, E. M. M. Perfil da pré-eclâmpsia/eclâmpsia e síndrome HELLP no Rio Grande do Norte-Uma proposta de integração do ensino- sistema SUS In: XVIII JORADA DE GINECOLOGIA E OBSTETRÍCIA DO RN, 2005, MOSSORÓ-RN. XVIII JORADA DE GINECOLOGIA E OBSTETRÍCIA DO RN. , 2005.
DANTAS, E. M. M. ROTURA HEPÁTICA ESPONTÂNEA NA GRAVIDEZ - RELATO DE CASO In: 50º CONGRESSO BRASILEIRO DE GINECOLOGIA E OBSTETRÍCIA, 2003, RECIFE-PE. 50º CONGRESSO BRASILEIRO DE GINECOLOGIA E OBSTETRÍCIA. , 2003.
7 REFERÊNCIAS
(1) Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986 Sep;93(9):898-908.
(2) Stevens JM. Gynaecology from ancient Egypt: The papyrus Kahun: A translation of the oldest treatise on gynaecology that has survived from the ancient world. Med J Aust 1975 Dec 20;2(25-26):949-52.
(3) Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003 Mar;41(3):437-45. (4) Rippmann ET. [The dead end in toxemia research]. Ther Ggw 1971 Nov;110(11):1619. (5) Steegers EA, von DP, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010 Aug
21;376(9741):631-44.
(6) Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006 Apr 1;367(9516):1066-74.
(7) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000 Jul;183(1):S1-S22.
(8) Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005 Feb 26;365(9461):785- 99.
(9) Borzychowski AM, Croy BA, Chan WL, Redman CW, Sargent IL. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol 2005 Oct;35(10):3054-63.
(10) Oudejans CB, van DM, Oosterkamp M, Lachmeijer A, Blankenstein MA. Genetics of preeclampsia: paradigm shifts. Hum Genet 2007 Jan;120(5):607-12.
(11) Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005 Feb;105(2):402-10.
(12) BUCHAN TW. Convulsions in childhood; an epidemiological note on their association with epilepsy, eclampsia, and stillbirth. Br Med J 1950 Jul 1;2(4669):22-3.
(13) Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001 Jan 20;357(9251):209-15.
(14) Chari RS, Friedman SA, O'Brien JM, Sibai BM. Daily antenatal testing in women with severe preeclampsia. Am J Obstet Gynecol 1995 Oct;173(4):1207-10.
(15) Martin JN, Jr., May WL, Rinehart BK, Martin RW, Magann EF. Increasing maternal weight: a risk factor for preeclampsia/eclampsia but apparently not for HELLP syndrome. South Med J 2000 Jul;93(7):686-91.
(16) Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995 Feb;172(2 Pt 1):642-8.
(17) Tabiasco J, Rabot M, guerre-Girr M, El CH, Berrebi A, Parant O, et al. Human decidual NK cells: unique phenotype and functional properties -- a review. Placenta 2006 Apr;27 Suppl A:S34-S39.
(18) Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006 Sep;12(9):1065-74.
(19) Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res 2008 Jan;75(1):1-8.
(20) Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173-92.
(21) Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) 2006 Apr;110(4):443-58.
(22) Thomson AJ, Telfer JF, Young A, Campbell S, Stewart CJ, Cameron IT, et al.
Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 1999 Jan;14(1):229-36.
(23) Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998 Jul;179(1):80-6.
(24) Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994
Dec;84(6):937-40.
(25) Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre- eclampsia. Br J Obstet Gynaecol 1995 Jan;102(1):20-5.
(26) Clark P, Boswell F, Greer IA. The neutrophil and preeclampsia. Semin Reprod Endocrinol 1998;16(1):57-64.
(27) Sattar N, Greer IA, Louden J, Lindsay G, McConnell M, Shepherd J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab 1997 Aug;82(8):2483-91.
(28) Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001 Nov;98(5 Pt 1):757-62.
(29) Dekker G, Robillard PY. The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis. J Reprod Immunol 2003 Aug;59(2):245-51.
(30) Kilpatrick DC, Liston WA, Gibson F, Livingstone J. Association between susceptibility to pre-eclampsia within families and HLA DR4. Lancet 1989 Nov 4;2(8671):1063-5. (31) Hoff C, Stevens RG, Mendenhall H, Peterson RD, Spinnato JA. Association between risk
for pre-eclampsia and HLA DR4. Lancet 1990 Mar 17;335(8690):660-1.
(32) Ward JE, Caunt JA, Alderson J. Management of pre-eclampsia. Br J Anaesth 1996 Jun;76(6):889-90.
(33) Zhang C, Williams MA, Edwards KL, Austin MA. Trp64Arg polymorphism of the beta3- adrenergic receptor gene, pre-pregnancy obesity and risk of pre-eclampsia. J Matern Fetal Neonatal Med 2005 Jan;17(1):19-28.
(34) Morgan L, Baker P, Broughton PF, Kalsheker N. Pre-eclampsia and the angiotensinogen gene. Br J Obstet Gynaecol 1995 Jun;102(6):489-90.
(35) Morgan L, Crawshaw S, Baker PN, Broughton PF, Kalsheker N. Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br J Obstet Gynaecol 1999 Mar;106(3):244-51.
(36) Huber A, Hefler L, Tempfer C, Zeisler H, Lebrecht A, Husslein P. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2002 Feb;81(2):168-71.
(37) Livingston JC, Park V, Barton JR, Elfering S, Haddad B, Mabie WC, et al. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels. Am J Obstet Gynecol 2001 May;184(6):1273-7.
(38) Liston WA, Kilpatrick DC. Is genetic susceptibility to pre-eclampsia conferred by homozygosity for the same single recessive gene in mother and fetus? Br J Obstet Gynaecol 1991 Nov;98(11):1079-86.
(39) Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J. Immunologic Characteristics of Preeclampsia, a Comprehensive Review. Am J Reprod Immunol 2010 Sep 5.
(40) Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998 Aug;40(2):102-11.
(41) Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997 Mar;37(3):240-9.
(42) Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J. Immunologic Characteristics of Preeclampsia, a Comprehensive Review. Am J Reprod Immunol 2010 Sep 5.
(43) Kincaid-Smith P, BULLEN M. BACTERIURIA IN PREGNANCY. Lancet 1965 Feb 20;1(7382):395-9.
(44) Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007 Jul;58(1):21-30.
(45) Nakabayashi M, Sakura M, Takeda Y, Sato K. Elevated IL-6 in midtrimester amniotic fluid is involved with the onset of preeclampsia. Am J Reprod Immunol 1998
May;39(5):329-34.
(46) Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996 Dec;32(2):157-69.
(47) Bartha JL, Romero-Carmona R, Escobar-Llompart M, Comino-Delgado R. The
relationships between leptin and inflammatory cytokines in women with pre-eclampsia. BJOG 2001 Dec;108(12):1272-6.
(48) Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J. Immunologic Characteristics of Preeclampsia, a Comprehensive Review. Am J Reprod Immunol 2010 Sep 5.
(49) Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol 1999 Sep 15;163(6):3491-5.
(50) Orange S, Horvath J, Hennessy A. Preeclampsia is associated with a reduced interleukin- 10 production from peripheral blood mononuclear cells. Hypertens Pregnancy
2003;22(1):1-8.
(51) Wilczynski JR, Tchorzewski H, Glowacka E, Banasik M, Lewkowicz P, Szpakowski M, et al. Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediators Inflamm 2002 Apr;11(2):105-11.
(52) Makris A, Xu B, Yu B, Thornton C, Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 2006 Apr;27(4-5):445-51.
(53) Mbah AK, Kornosky JL, Kristensen S, August EM, Alio AP, Marty PJ, et al. Super- obesity and risk for early and late pre-eclampsia. BJOG 2010 Jul;117(8):997-1004. (54) Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab 2007
Dec;18(10):365-70.
(55) Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001 Nov 24;323(7323):1213-7. (56) Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic
heart disease: a retrospective cohort study of 129,290 births. Lancet 2001 Jun 23;357(9273):2002-6.
(57) Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005 Nov 19;366(9499):1797-803.
(58) Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003 Apr 19;326(7394):845.
(59) Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005 Nov;112(11):1486-91. (60) Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of
cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007 Nov 10;335(7627):974.
(61) Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation 2010 Aug 10;122(6):579-84. (62) Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al.
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 Dec 4;288(21):2709-16.
(63) Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003 Sep 30;108(13):1541-5.
(64) Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 Jul;15(7):539-53.
(65) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood
Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 May 16;285(19):2486-97. (66) Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence
for a common antecedent? Diabetes Care 1999 Apr;22 Suppl 3:C25-C30.
(67) Bigazzi R, Bianchi S. Insulin resistance, metabolic syndrome and endothelial dysfunction. J Nephrol 2007 Jan;20(1):10-4.
(68) Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem 2006;13(14):1655-65.
(69) Groop PH, Forsblom C, Thomas MC. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab 2005 Dec;1(2):100-10.
(70) Rask-Madsen C, King GL. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007 Jan;3(1):46-56.
(71) Brundtland GH. From the World Health Organization. Reducing risks to health, promoting healthy life. JAMA 2002 Oct 23;288(16):1974.
(72) Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord 1995 May;19 Suppl 1:S52-S59.
(73) Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998;20(2):157-72.
(74) Lakka TA, Laaksonen DE, Lakka HM, Mannikko N, Niskanen LK, Rauramaa R, et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 2003 Aug;35(8):1279-86.
(75) Lakka TA, Laaksonen DE, Lakka HM, Mannikko N, Niskanen LK, Rauramaa R, et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 2003 Aug;35(8):1279-86.
(76) Monteiro CA, Mondini L, de Souza AL, Popkin BM. The nutrition transition in Brazil. Eur J Clin Nutr 1995 Feb;49(2):105-13.
(77) Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990
Aug;163(2):460-5.
(78) Small MJ, Kershaw T, Frederic R, Blanc C, Neale D, Copel J, et al. Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti. J Matern Fetal Neonatal Med 2005 Nov;18(5):343-8.
(79) Ventura SJ, Anderson RN, Martin JA, Smith BL. Births and deaths: preliminary data for 1997. Natl Vital Stat Rep 1998 Oct 7;47(4):1-41.
(80) Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003 Jul;102(1):181-92.
(81) Sibai BM. Prevention of preeclampsia: a big disappointment. Am J Obstet Gynecol 1998 Nov;179(5):1275-8.
(82) harlow F, Brown M. The diversity of diagnoses of preeclampsia. Hypertens Pregnancy 20(1), 57-67. 2001.
Ref Type: Generic
(83) Martin JN, Jr., May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999 Jun;180(6 Pt 1):1407-14.
(84) Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005 Mar 12;330(7491):576-80.
(85) Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999
May;16(5):442-3.
(86) Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001 Jul 25;286(4):421-6.
(87) Lambers Heerspink HJ, Brinkman JW, Bakker SJ, Gansevoort RT, de ZD. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr Opin Nephrol Hypertens 2006 Nov;15(6):631-6.
(88) Klausen KP, Scharling H, Jensen JS. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med 2006 Sep;260(3):231-7.
(89) Lambers Heerspink HJ, Brinkman JW, Bakker SJ, Gansevoort RT, de ZD. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr Opin Nephrol Hypertens 2006 Nov;15(6):631-6.
(90) Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999 Feb;22(2):307-13.
(91) Klausen KP, Scharling H, Jensen JS. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med 2006 Sep;260(3):231-7.
(92) Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983 May 27;249(20):2792-8.
(93) Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 1998 Aug;32(2):255-9.
(94) Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999 Aug 11;282(6):539-46.
(95) Verdecchia P. Prognostic value of ambulatory blood pressure : current evidence and clinical implications. Hypertension 2000 Mar;35(3):844-51.
(96) Secretaria Municipal de Meio Ambiente e Urbanismo. MAPAS DO PLANO DIRETOR DE NATAL. 21-6-2007. Disponível em:
http://www.natal.rn.gov.br/semurb/paginas/ctd-106.html Acessado em: 12/07/2010.
Ref Type: Generic
(97) Geven WB, Niezen-Koning KE, Timmer A, van Loon AJ, Wanders RJ, van Spronsen FJ. Pre-eclampsia in a woman whose child suffered from lethal carnitine-acylcarnitine translocase deficiency. BJOG 2007 Aug;114(8):1028-30.
(98) Elliot GT. Puerperal eclampsia in the eight month extraordinary family history. Appleton , 291-293. 1873. New York.
Ref Type: Generic
(99) Bezerra PF, Leao MD, Queiroz J.W., Pereira FV, Melo E.D., Oliveira H.N., et al. Family history of hypertension is a risk factor for development of eclampsia and HELLP
syndrome in a Brazilian population. Acta Obstet.Gynecol.Scand. revision. 2009. Ref Type: Generic
(100) Hollenberg NK. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. Curr Hypertens Rep 2003 Aug;5(4):288-9.
APÊNDICE A - Formulário de Pesquisa
RISCO DE DOENÇA CARDIOVASCULAR EM MULHERES COM HISTÓRIA DE DISTÚRBIO HIPERTENSIVO DA GRAVIDEZ
1 – DADOS PESSOAIS: Data: __/__/____
Registro: ________
Nome: _____________________________________________________________ Data de Nascimento: ___/___/_____ Idade: __________
Endereço: _______________________________________________________Nº _______ Bairro: ____________________ Cidade: _________________ Estado: _ CEP: ________ Telefone: ( ) _______________ Celular: ( ) ______________
2. ESCOLARIDADE:
( 0 ) Não Alfabetizada ( 1 ) Ensino Básico Completo ( 2 ) Ensino Básico Completo
( 3 ) Ensino Médio Incompleto ( 4 ) Ensino Médio Completo ( 5 ) Superior Incompleto
( 6 ) Superior Completo
3 - CONDIÇÕES DE VIDA:
Ocupação: ___________ Inserção no mercado de trabalho: ( ) ____________________ ( 1 ) Não ( 2 ) Sim Nº de Empregos: Carga Horária: ___
4. RENDA FAMILIAR:
( 0 ) Menor que 1 salário mínimo ( 1 ) Entre 1 e 3 salários mínimos ( 2 ) Entre 3 e 5 salários mínimos ( 3 ) Acima de 5 salários mínimos 5 – HÁBITOS DE VIDA:
( ) Etilismo ( 0 ) Não ( 1 ) Pouco freqüente ( 2 ) Freqüente Como? ____ ( ) Tabagismo ( 0 ) Não ( 1 ) Pouco freqüente ( 2 ) Freqüente Quantos/dia? ( ) Prática de Exercícios ( 0 ) Não ( 1 ) Pouco frequente
( 2 ) Freqüente Quantas/semana?
( ) Consumo de Sal ( 0 ) Não ( 1 ) Pouca quantidade ( 2 ) Em excesso Como?
( ) Alimentos Gordurosos ( 0 ) Não ( 1 ) Pouca quantidade ( 2 ) Em excesso Como?
( ) Ingestão de Cafeína ( 0 ) Não ( 1 ) Pouca quantidade ( 2 ) Em excesso Quanto/dia?
( ) Ingestão de Fibras ( 0 ) Não ( 1 ) Pouca quantidade ( 2 ) Grande Quantidade Como?
( ) Ingestão de Frutas ( 0 ) Não ( 1 ) Pouca quantidade
( 2 ) Grande Quantidade Como?
( ) Ingestão de Vegetais ( 0 ) Não ( 1 ) Pouca quantidade ( 2 ) Grande Quantidade Como?
6 – CONDIÇÕES DE SAÚDE ATUAL:
Distúrbios psiquiátricos ( ) (0)Não sabe; (1)Não; (2)Sim Quais?
Pré-eclâmpsia ( ) (0)Não sabe; (1)Não; (2)Sim Mesmo pai (parceiro)? (1)Não (2)Sim
Eclâmpsia ( ) (0)Não sabe; (1)Não; (2)Sim Mesmo pai (parceiro)? (1)Não (2)Sim
HELLP ( ) (0)Não sabe; (1)Não; (2)Sim Mesmo pai (parceiro)? (1)Não (2)Sim
Hipertensão crônica ( ) (0)Não sabe; (1)Não; (2)Sim Hipertensão arterial ( ) (0)Não sabe; (1)Não; (2)Sim Diabetes Mellitus ( ) (0)Não sabe; (1)Não; (2)Sim
DPOC ( ) (0)Não sabe; (1)Não; (2)Sim
Angina do peito ( ) (0)Não sabe; (1)Não; (2)Sim Infarto agudo do miocárdio prévio ( ) (0)Não sabe; (1)Não; (2)Sim Doença renal ( ) (0)Não sabe; (1)Não; (2)Sim Faz Hemodiálise ( ) (0)Não sabe; (1)Não; (2)Sim Lúpus eritematoso ( ) (0)Não sabe; (1)Não; (2)Sim Outra colagenose ( ) (0)Não sabe; (1)Não; (2)Sim Qual? Isquemia cerebral transitória ( ) (0)Não sabe; (1)Não; (2)Sim
AVC ( ) (0)Não sabe; (1)Não; (2)Sim
Alterações cognitivas ( ) (0)Não sabe; (1)Não; (2)Sim Retinopatia hipertensiva ( ) (0)Não sabe; (1)Não; (2)Sim Embolia pulmonar ( ) (0)Não sabe; (1)Não; (2)Sim
Trombose venosa perifér. ( ) (0)Não sabe; (1)Não; (2)Sim Insuficiência cardíaca ( ) (0)Não sabe; (1)Não; (2)Sim Edema agudo pulmão ( ) (0)Não sabe; (1)Não; (2)Sim Transfusão sangüínea ( ) (0)Não sabe; (1)Não; (2)Sim Cirurgias ( ) (0)Não sabe; (1)Não; (2)Sim Qual? Revascularização do miocárdio prévia ( ) (0)Não sabe; (1)Não; (2)Sim Angioplastia prévia ( ) (0)Não sabe; (1)Não; (2)Sim Disfunção sexual ( ) (0)Não sabe; (1)Não; (2)Sim Apnéia do sono ( ) (0)Não sabe; (1)Não; (2)Sim Alergias ( ) (0)Não sabe; (1)Não; (2)Sim 7 – MONITORIZAÇÃO DA PRESSÃO ARTERIAL:
( 0 ) Não ( 1 ) Sim Com qual freqüência: _________________
8 – CONHECIMENTO DOS FATORES DE RISCO PARA DOENÇAS CARDIOVASCULARES:
( 0 ) Não ( 1 ) Sim Quais? ____________________________ 9 – EXAMES LABORATORIAIS: ( 0 ) Normal ( 1 ) Diminuído VALORES DE
REFERÊNCIA VALORES ENCONTRADOS
01 ( ) Glicemia de Jejum (> 90 mg %) 02 ( ) Tolerância à glicose 03 ( ) Uréia (>20 mg%) 04 ( ) Creat. (>0.8 mg%) 05 ( ) Ác. úrico (>4mg%) 06 ( ) Colesterol total 07 ( ) HDL 08 ( ) triglicérides 09 ( ) TGO 10 ( ) TGP 11 ( ) Gama GT 12 ( ) PCR ultrasensível 13 ( ) Microalbuminúria 14 ( ) Proteinúria
10 – DADOS REFERENTES A GRAVIDEZES SUBSEQUENTES:
( ) As gravidezes transcorreram normalmente ( 0 );As gravidez transcorreram com alguma intercorrência ( 1 )
Em qual gravidez houve intercorrência? que tipo? ________
( ) Uso de medicamentos(0); Não houve uso de medicamentos ( 1 )Qual? 11 – EXAME FÍSICO: ESTADO GERAL: ( ) 1 = Bom 2 = Regular 3 = Comprometido AVAL. NEUROLÓGICA Exame de fundo de olho Estreitamento arteriolar 1= não 2= sim Papiledema 1= não 2= sim Cruzamentos arteriovenosos patológicos ( ) 1= não 2= sim Hemorragias 1=não 2= sim CONVULSÕES: ( ) 1 = Não 2 = Generalizadas No ___ 3 = Focais No ___ PELE E MUCOSAS temperatura ( ) 1 = afebril 2 = febril 3 = hipotermia grau de hidratação ( ) 1 = hidratado 2 = desidratado cor ( ) 1 = corado 2 = descorado icterícia (++++/4+) 1= Anicterico 2= Icterico (+) RESPIRATÓRIO Padrão ( ) 1 = eupnéico 2 = dispnéico 3 = taquidispnéico 4 = bradidispnéico Ausculta Pulmonar Murmúrio vesicular ( ) 1 = presente 2 = ausente 3 = diminuído local: ________ Estertores ( ) 1= presente 2= ausente Roncos ( ) 1= presente 2= ausente Sibilos ( ) 1= presente 2= ausente AUSCULTA CARDÍACA Íctus ( ) (1) não (2) sim Arritmias( ) (1) não (2) sim 3ª bulha( ) (1) não (2) sim 4ª bulha ( ) (1) não (2) sim PESCOÇO Artérias carótidas Estase venosa ( ) (1) sim (2) não TIREÓIDE: ( ) 1 = Normal 2 = Palpável EDEMA: ( ) 1 = Ausente 2 = MMII(+)/4 3= MMII (+ +)/4 4= MMII (+++) / 4 5= MMII (++++) / 4 6 = Face 7 = Mãos 8 = Genitália 9 = Parede abdominal 10= Generalizado leve 11= Anasarca GÊNITO-URINÁRIO: ( ) 1 = sonda vesical de demo 2 = sonda vesical de alívio 3 = micção espontânea
aspecto da urina (1) sim (2) n ( ) hemoglobinúria ( ) hematúria ( ) concentrada ( ) límpida ( ) presença de sedimento volume / horário ( ) NI s/ estímulo ( ) necessita estímulo ( ) oligúria mesmo c/ estím ( ) anúria ( ) poliúria ( ) disúria EXTREMIDADES Pulsos braquiais ( ) (1) ausente (2) débil (3) normal Pulsos radiais ( ) (1) ausente (2) débil (3)
3= Icterico (++) 4= Icterio (+++) 5= Icterico (++++) PESO:________ Altura:_______ IMC:__________ OBESIDADE: ( ) 1 = Não 2 = Sim RELAÇÃO CINTURA QUADRIL ( 1) Normal (2) Aumentada Circunferência da cintura (1) Normal ( 2) Aumentada CARDIOVASCULAR frequência cardíaca ( ) 1 = normal 2 = taquicardia (100bpm) 3 = bradicardia ( 60 bpm) ritmo ( ) 1= regular 2 = irregular 3 = Bócio difuso 4 = Bócio nodular
ABDOME: (1) não (2) sim ( ) plano ( ) distendido ( ) globoso ( ) flácido ( ) rígido ( ) doloroso à palpação ( ) timpânico ( ) ascítico
hepatomegalia (1) não (2) sim se sim:______cm VARIZES: 01( ) Não 02( ) Em MMII 03( ) Em genitália normal Pulsos femorais ( ) (1) ausente (2) débil (3) normal
Pulsos tibiais posteriores ( ) (1) ausente (2) débil (3) normal Pulsos Pediosos ( ) (1) ausente (2) débil (3) normal OUTROS:
APÊNDICE B – Termo de Consentimento Livre e Esclarecido (TCLE)
UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE